Inhibitors of tyrosine kinase enzymatic activity represent a promising new class of antineoplastic agents. Although clinical studies performed over the last decade give more insight on the potential therapeutic applications of such drugs, identification of the individual patients who might benefit f
Synthesis of [11C]gefitinib for imaging epidermal growth factor receptor tyrosine kinase with positron emission tomography
β Scribed by Daniel P. Holt; Hayden T. Ravert; Robert F. Dannals; Martin G. Pomper
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- French
- Weight
- 128 KB
- Volume
- 49
- Category
- Article
- ISSN
- 0022-2135
No coin nor oath required. For personal study only.
β¦ Synopsis
We have synthesized N-(3-chloro-4-fluorophenyl)-7-[ 11 C]methoxy-6- [3-(morpholin-4yl)propoxy]quinazolin-4-amine, [ 11 C]gefitinib ([ 11 C]Iressa), a high affinity (IC 50 = 2 nM) inhibitor of the epidermal growth factor receptor tyrosine kinase (EGFR-TK), in solution and in a semi-automated stainless loop methylation system using [ 11 C]methyl triflate. The trapping efficiency for [ 11 C]methyl triflate in solution was higher than in the solvent film generated in the loop system, thus the overall radiochemical yield was considerably higher for the synthesis in solution. The average radiochemical yield for the solution chemistry was 15% with an average specific radioactivity of approximately 9000 mCi/mmole at EOS in one step from its corresponding desmethyl phenol precursor.
π SIMILAR VOLUMES
The novel 2-mercaptoimidazole derivatives, 1-[4-((2-methoxyphenyl)-1-piperazinyl)butyl]-2-mercaptoimidazole (3) and methyl[4-((2-methoxyphenyl)-1-piperazinyl))butyl] (2-mercapto-1-methylimidazol-5-yl)methanamide ( 8), were efficiently labelled with 11 C through methylation of the thioketone function